BEHRICHORM(R) HEPARIN OWLD115

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05,06 report with the FDA on 2013-03-29 for BEHRICHORM(R) HEPARIN OWLD115 manufactured by Siemens Healthcare Diagnostics Products Gmbh.

Event Text Entries

[16910197] A customer complains of a high berichrom(r) heparin result relative to a result obtained by an alternate methodology. The customer states that the berichrom heparin elevated result was accepted on a patient sample and alleges it led to a decision to change the heparin treatment of the patient. The patient suffered a stroke.
Patient Sequence No: 1, Text Type: D, B5


[16931108] The cause of the discrepancy versus the alternate methodology is unknown. Correlation to the alternate assay is not established. The complaint is under investigation by siemens healthcare diagnostics.
Patient Sequence No: 1, Text Type: N, H10


[34401705] Original mdr was filed 2013-03-29. Further investigation confirmed that the basis of the customer complaint was customer correlation to an alternate assay which is not established or claimed by siemens healthcare diagnostics. At the time of the complaint, the berichrom heparin control results were within the qc control ranges. Siemens assessment showed that user processed the sample with a modified application (change of washing step) and reported a value reported above the calibrated range. Therefore, a clear link of the insult to the heparin measurement cannot be drawn. In addition, differences between the methods discussed is known from proficiency trials and reflects several technical and design differences. Additionally, evaluation of the berichrom(r) heparin product, owld, was conducted relative to complaints of low recoveries with reagent time on board the instrument. It was concluded that if a change of heparin level is observed during on board stability, it will be shown by a lower control recovery. It is extremely unlikely that an erroneously low heparin value may be reported which may trigger a higher dose of heparin therapy which could slightly increase the risk of bleeding. The potential of an adverse event to the patient is considered to be very unlikely because only the lower therapeutic range is affected. (in this instance which is unrelated to on board stability, discrepant elevated results were alleged).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number9610806-2013-00006
MDR Report Key3027571
Report Source01,05,06
Date Received2013-03-29
Date of Report2013-10-07
Date of Event2013-03-18
Date Mfgr Received2013-10-07
Device Manufacturer Date2012-02-24
Date Added to Maude2013-03-29
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactJAMES MORGERA
Manufacturer StreetGLASGOW BUSINESS COMMUNITY PO BOX 6101
Manufacturer CityNEWARK DE 197146101
Manufacturer CountryUS
Manufacturer Postal197146101
Manufacturer Phone3026318356
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW
Manufacturer StreetGLASGOW BUSINESS COMMUNITY 500 GBC DRIVE
Manufacturer CityNEWARK DE 19702350
Manufacturer CountryUS
Manufacturer Postal Code19702 3504
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameBEHRICHORM(R) HEPARIN
Generic NameBEHRICHORM(R) HEPARIN
Product CodeKFF
Date Received2013-03-29
Catalog NumberOWLD115
Lot Number41523
Device Expiration Date2014-11-21
OperatorMEDICAL TECHNOLOGIST
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
Manufacturer Address76 EMIL VON BEHRING STRASSE MARBURG, 35041 GM 35041


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2013-03-29

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.